🔎 Trials Near Me

首页 › 肺癌 › 马萨诸塞州 › Worcester

Worcester MA 肺癌临床试验

11项针对 肺癌的研究正在 Worcester及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。

官方研究文本（英文）

正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

招募中3 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

招募中3 期
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford · 距离 17 英里
70 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

招募中3 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

招募中3 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06498635

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

招募中3 期
  • Reliant Medical Group Inc, Worcester
18 至 100 岁 · 所有性别 · 更新于 2026年9月25日 · NCT05920356

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

招募中3 期
  • University of Massachusetts Memorial Medical Center, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06793215

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

招募中3 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

招募中2 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年6月3日 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

招募中2 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 Minutes · 所有性别 · 更新于 2026年5月5日 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

招募中2/3 期
  • UMass Memorial Medical Center - University Campus, Worcester
18 岁及以上 · 所有性别 · 更新于 2026年5月5日 · NCT06616584

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

招募中观察性研究
  • Massive Bio SYNERGY-AI site, Worcester
所有年龄段 · 所有性别 · 更新于 2025年10月28日 · NCT03452774

其他城市的 肺癌试验

Worcester的其他研究

数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。